Aquestive Therapeutics Announces $75M Strategic Funding Agreement with RTW to Support the Potential Launch of Anaphylm(TM) (epinephrine) Sublingual Film
Aquestive Therapeutics Announces $75M Strategic Funding Agreement with RTW to Support the Potential Launch of Anaphylm(TM) (epinephrine) Sublingual Film GlobeNewswire August 14, 2025 Anaphylm launch funding of $75 million committed by RTW, subject to FDA approval of Anaphylm and other conditions Strategic financing will further strengthen the Company's balance sheet in advance of potential commercialization […]